Open Recommendations
Recommendation Number | Significant Recommendation | Recommended Questioned Costs | Recommended Funds for Better Use | Additional Details | |
---|---|---|---|---|---|
1 | No | $0 | $0 | ||
We recommend that the Plan research its ER copayments from 2020 to determine the extent to which members were negatively impacted by the discrepancy and rectify any member overpayments. | |||||
4 | No | $0 | $0 | ||
We recommend that the Plan strengthen its internal policies and procedures to ensure that it eliminates variances in its FEHBP rate development components. | |||||
14 | No | $0 | $0 | ||
We recommend that the Plan update its FWA referral process to comply with CL 2017-13 and the supplemental guidance to the Guidelines. | |||||
5 | No | $0 | $0 | ||
We recommend that the Plan strengthen its internal policies and procedures to ensure that pharmacy rebates are properly allocated to the FEHBP and removed from the pharmacy claims in the premium rate development. | |||||
6 | No | $0 | $0 | ||
We recommend the Plan update its system and procedural controls for its claims processing system. | |||||
8 | No | $0 | $0 | ||
We recommend that the Plan ensure that appropriate copayments are applied to claims as defined in the FEHBP benefit brochure. | |||||
9 | No | $0 | $0 | ||
We recommend that the Plan ensure claims are not processed for out of network providers as stated in the FEHBP benefit brochure. | |||||
10 | No | $0 | $0 | ||
We recommend that the Plan ensure that benefits are properly coordinated, when applicable, with Medicare benefits. | |||||
12 | No | $0 | $0 | ||
We recommend that the Plan develop formal written policies and procedures to notify ASG of claims submitted, whether paid or not, after a provider is debarred or suspended in accordance with the Guidelines. | |||||
16 | No | $0 | $0 | ||
We recommend that the Plan strengthen its procedures for requesting proof of family member eligibility and removing ineligible family member enrollments as outlined in CL 2020-16. |